KARD

NASDAQ 已收盘

Kardigan

12.52 USD
▲+0.20+1.62%
盘后 13.89 0.00%
2026-11-19
市值
$1.08B
市盈率
—
EPS
-7.83
股息率
—
52 周区间
12.23 – 27.00
成交量
977.80K
Beta
—
目标价
41.00
52W 低 12.2352W 高 27.00
价格走势

公司简介

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking. The...